The landscape of BRCA1 and BRCA2 large rearrangements in an international cohort of over 20 000 ovarian tumors identified using next-generation sequencing.
Saved in:
| Title: | The landscape of BRCA1 and BRCA2 large rearrangements in an international cohort of over 20 000 ovarian tumors identified using next-generation sequencing. |
|---|---|
| Authors: | Jones MA; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Timms KM; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Hatcher S; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Cogan ES; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Comeaux MS; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Perry M; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Morris B; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Swedlund B; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Elks CE; Oncology R&D, AstraZeneca, Cambridge, UK., Lao-Sirieix P; Oncology R&D, AstraZeneca, Cambridge, UK., Dearden S; Oncology R&D, AstraZeneca, Cambridge, UK., Egile C; Oncology R&D, AstraZeneca, Cambridge, UK., Brown JS; Oncology R&D, AstraZeneca, Cambridge, UK., Harrington EA; Oncology R&D, AstraZeneca, Cambridge, UK., Hodgson D; Oncology R&D, AstraZeneca, Cambridge, UK., Stern M; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Slavin TP; Myriad Genetics, Inc, Salt Lake City, Utah, USA., Mancini-DiNardo D; Myriad Genetics, Inc, Salt Lake City, Utah, USA. |
| Source: | Genes, chromosomes & cancer [Genes Chromosomes Cancer] 2023 Oct; Vol. 62 (10), pp. 589-596. Date of Electronic Publication: 2023 May 24. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9007329 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2264 (Electronic) Linking ISSN: 10452257 NLM ISO Abbreviation: Genes Chromosomes Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37222498 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The landscape of BRCA1 and BRCA2 large rearrangements in an international cohort of over 20 000 ovarian tumors identified using next-generation sequencing. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jones+MA%22">Jones MA</searchLink>; Myriad Genetics, Inc, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Timms+KM%22">Timms KM</searchLink>; Myriad Genetics, Inc, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Hatcher+S%22">Hatcher S</searchLink>; Myriad Genetics, Inc, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Cogan+ES%22">Cogan ES</searchLink>; Myriad Genetics, Inc, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Comeaux+MS%22">Comeaux MS</searchLink>; Myriad Genetics, Inc, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Perry+M%22">Perry M</searchLink>; Myriad Genetics, Inc, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Morris+B%22">Morris B</searchLink>; Myriad Genetics, Inc, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Swedlund+B%22">Swedlund B</searchLink>; Myriad Genetics, Inc, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Elks+CE%22">Elks CE</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Lao-Sirieix+P%22">Lao-Sirieix P</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Dearden+S%22">Dearden S</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Egile+C%22">Egile C</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Brown+JS%22">Brown JS</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Harrington+EA%22">Harrington EA</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Hodgson+D%22">Hodgson D</searchLink>; Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Stern+M%22">Stern M</searchLink>; Myriad Genetics, Inc, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Slavin+TP%22">Slavin TP</searchLink>; Myriad Genetics, Inc, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Mancini-DiNardo+D%22">Mancini-DiNardo D</searchLink>; Myriad Genetics, Inc, Salt Lake City, Utah, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229007329%22">Genes, chromosomes & cancer</searchLink> [Genes Chromosomes Cancer] 2023 Oct; Vol. 62 (10), pp. 589-596. <i>Date of Electronic Publication: </i>2023 May 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007329 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1098-2264 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210452257%22">10452257 </searchLink><i>NLM ISO Abbreviation: </i>Genes Chromosomes Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37222498 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/gcc.23150 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 589 Titles: – TitleFull: The landscape of BRCA1 and BRCA2 large rearrangements in an international cohort of over 20 000 ovarian tumors identified using next-generation sequencing. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jones MA – PersonEntity: Name: NameFull: Timms KM – PersonEntity: Name: NameFull: Hatcher S – PersonEntity: Name: NameFull: Cogan ES – PersonEntity: Name: NameFull: Comeaux MS – PersonEntity: Name: NameFull: Perry M – PersonEntity: Name: NameFull: Morris B – PersonEntity: Name: NameFull: Swedlund B – PersonEntity: Name: NameFull: Elks CE – PersonEntity: Name: NameFull: Lao-Sirieix P – PersonEntity: Name: NameFull: Dearden S – PersonEntity: Name: NameFull: Egile C – PersonEntity: Name: NameFull: Brown JS – PersonEntity: Name: NameFull: Harrington EA – PersonEntity: Name: NameFull: Hodgson D – PersonEntity: Name: NameFull: Stern M – PersonEntity: Name: NameFull: Slavin TP – PersonEntity: Name: NameFull: Mancini-DiNardo D IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2023 Oct Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1098-2264 Numbering: – Type: volume Value: 62 – Type: issue Value: 10 Titles: – TitleFull: Genes, chromosomes & cancer Type: main |
| ResultId | 1 |